Question:

Do we need to report the JW modifier in an OPPS hospital setting when a drug is discarded?

Answer:

Yes, for OPPS hospitals, reporting this modifier is required for all separately payable drugs assigned status indicators G (Pass-through Drugs and Biologicals) or K (Nonpass-through Drugs and Nonimplantable Biologicals, including Therapeutic Radiopharmaceuticals) when an unused or discarded amount is documented and submitted for reimbursement.

This question was answered in our Coding Essentials for Infusion & Injection Therapy Services. For more hot topics relating to infusion services, please visit our store or call us at 1.800.252.1578, ext. 2.

Facebook
Twitter
LinkedIn

CPT® copyright 2024 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.

Unlock 50% off all 2024 edition books when you order by July 5! Use the coupon code CO5024 at checkout to claim this offer!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24